Abstract:Experimental Biology and Medicine, Ahead of Print. In recent years, with the increase of air pollution, smoking, aging, and respiratory infection, the incidence rate and mortality of lung diseases are increasing annually, which has become a major hazard to human health. N6-methyladenosine (m6A) RNA methylation is the most abundant modifications in eukaryotes, and such modified RNA can be specifically recognized and combined by m6A recognition proteins and then mediate RNA splicing, maturation, enucleation, degradation, and translation. More and more studies have revealed that the m6A modification is involved in the pathogenesis and development of some diseases; however, the mechanisms of m6A in lung diseases are poorly understood. In this review, we summarize the latest progress in the biological function of m6A modifications in lung diseases and discuss the potential therapeutic and prognostic strategies. The dysregulation of global m6A levels and m6A regulators may affect the occurrence and development of asthma, chronic obstructive pulmonary disease, lung cancer, and other lung diseases through inflammation and immune function. In lung cancer, this modification has an important impact on malignant cell proliferation, migration, invasion, and drug resistance. In addition, abnormally changed m6A-modified proteins in lung cancer tissue samples and circulating tumor cells (CTCs) may be used as diagnostic and prognostic markers of lung cancer. Models composed of multiple m6A regulators can be used to evaluate the risk prediction or prognosis of asthma and pulmonary fibrosis. In general, the in-depth study of m6A modifications is a frontier direction in disease research. It provides novel insights for understanding of the molecular mechanisms underlying disease occurrence, development, and drug resistance, as well as for the development of effective novel therapeutics.

Progress on N~6-methyladenosine Regulation of Immune Homeostasis Chinese Full Text English Full Text (MT)

Progress on &Amp;lt;italic&gt;n&lt;/italic&gt;&lt;sup&gt;6&lt;/sup&gt;-Methyladenosine Regulation of Immune Homeostasis

Rna N-6-Methyladenosine Methylation In Post-Transcriptional Gene Expression Regulation

The emerging roles of N6-methyladenosine RNA methylation in human cancers

N6-Methyladenosine (m6A) Modification in Natural Immune Cell-Mediated Inflammatory Diseases

Regulation of Antiviral Immune Response by N6-Methyladenosine of mRNA

A Review in Research Progress Concerning m6A Methylation and Immunoregulation

The Emerging Molecular Mechanism of M6a Modulators in Tumorigenesis and Cancer Progression

Exploring the impact of m6A modification on immune diseases: mechanisms and therapeutic implication

N6-methyladenosine Modification: an Important Player in the Tumor Immune Microenvironment.

N6-methyladenosine modifications: interactions with novel RNA-binding proteins and roles in signal transduction.

N<SUP>6</SUP>-methyladenosine as a biological and clinical determinant in colorectal cancer: progression and future direction

RNA m6A Modification in Immunocytes and DNA Repair: The Biological Functions and Prospects in Clinical Application

The roles of m<SUP>6</SUP>A RNA modifiers in human cancer

N 6-methyladenosine RNA methylation: From regulatory mechanisms to potential clinical applications

The Importance of N6-methyladenosine Modification in Tumor Immunity and Immunotherapy.

Role of m6A modifications in immune evasion and immunotherapy

N6-Methyladenosine RNA Modification in the Tumor Immune Microenvironment: Novel Implications for Immunotherapy

The M6a Epitranscriptome Opens a New Charter in Immune System Logic

Emerging role of N6-methyladenosine RNA methylation in lung diseases

N 6 ‐methyladenosine Steers RNA Metabolism and Regulation in Cancer